Mirum Pharmaceuticals (MIRM) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.52
-0.43
-0.35
-0.26

Details

Expected EPS
-0.329922
Actual EPS
-0.3
Surprise EPS
0.03
Surprise Percent
+9.07%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -0.3 per share for Q2 2025.

0 Comments

Share your thoughts